[1] Beyrer C. Global prevention of HIV infection for neglected populations: men who have sex with men. Clin Infect Dis 2010;50(Suppl 3):S108 − 13. http://dx.doi.org/10.1086/651481.
[2] Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363(27):2587 − 99. http://dx.doi.org/10.1056/NEJMoa1011205.
[3] WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. https://apps.who.int/iris/handle/10665/186275. [2019-1-5].
[4] WHO. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV. https://www.who.int/publications/i/item/WHO-CDS-HIV-18.51.[2019-1-28].
[5] Wang HY, Zhang YH, Mei Z, Jia YR, Leuba SI, Zhang J, et al. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP). BMC Infect Dis 2019;19(1):721. http://dx.doi.org/10.1186/s12879-019-4355-y.
[6] Hu Y, Zhong XN, Peng B, Zhang Y, Liang H, Dai JH, et al. Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in Western China. BMC Infect Dis 2018;18(1):575. http://dx.doi.org/10.1186/s12879-018-3497-7.